ATE503186T1 - Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen proben - Google Patents
Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen probenInfo
- Publication number
- ATE503186T1 ATE503186T1 AT05731863T AT05731863T ATE503186T1 AT E503186 T1 ATE503186 T1 AT E503186T1 AT 05731863 T AT05731863 T AT 05731863T AT 05731863 T AT05731863 T AT 05731863T AT E503186 T1 ATE503186 T1 AT E503186T1
- Authority
- AT
- Austria
- Prior art keywords
- situ
- testic
- cancer
- detecting
- derived cancers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400647 | 2004-04-23 | ||
DKPA200402032 | 2004-12-30 | ||
PCT/DK2005/000280 WO2005103703A2 (en) | 2004-04-23 | 2005-04-21 | Use of novel biomarkers for detection of testicular carcinoma in situ and derived cancers in human samples |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE503186T1 true ATE503186T1 (de) | 2011-04-15 |
Family
ID=34965534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05731863T ATE503186T1 (de) | 2004-04-23 | 2005-04-21 | Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen proben |
Country Status (9)
Country | Link |
---|---|
US (1) | US20090298053A1 (de) |
EP (3) | EP2273271A3 (de) |
JP (2) | JP2007533311A (de) |
AT (1) | ATE503186T1 (de) |
AU (1) | AU2005236125C1 (de) |
CA (1) | CA2563917A1 (de) |
DE (1) | DE602005027065D1 (de) |
DK (1) | DK1747465T3 (de) |
WO (1) | WO2005103703A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007022041A2 (en) * | 2005-08-11 | 2007-02-22 | Novartis Ag | Mutations and polymorphisms of hdac3 |
JP5099535B2 (ja) * | 2005-11-17 | 2012-12-19 | 独立行政法人産業技術総合研究所 | Kank4遺伝子の癌治療及び癌検出並びに創薬への利用 |
US20080241110A1 (en) * | 2005-11-29 | 2008-10-02 | Nevada Cancer Institute | Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS) |
WO2009029712A1 (en) * | 2007-08-29 | 2009-03-05 | Genstruct, Inc. | Computer-aided discovery of biomarker profiles in complex biological systems |
EP2356449A1 (de) * | 2008-10-16 | 2011-08-17 | Rigshospitalet | In-situ-karzinomnachweis in samenpräparaten |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030147863A1 (en) * | 2001-12-17 | 2003-08-07 | Isis Pharmaceuticals Inc. | Antisense modulation of TFAP2C expression |
CN1703522A (zh) * | 2002-09-30 | 2005-11-30 | 肿瘤疗法科学股份有限公司 | 诊断睾丸精原细胞瘤的方法 |
GB0307206D0 (en) * | 2003-03-28 | 2003-04-30 | Axordia Ltd | Hyperproliferation |
-
2005
- 2005-04-21 EP EP10182313A patent/EP2273271A3/de not_active Withdrawn
- 2005-04-21 EP EP08172455A patent/EP2083273A1/de not_active Withdrawn
- 2005-04-21 WO PCT/DK2005/000280 patent/WO2005103703A2/en active Application Filing
- 2005-04-21 AT AT05731863T patent/ATE503186T1/de active
- 2005-04-21 CA CA002563917A patent/CA2563917A1/en not_active Abandoned
- 2005-04-21 EP EP05731863A patent/EP1747465B1/de not_active Not-in-force
- 2005-04-21 DK DK05731863.6T patent/DK1747465T3/da active
- 2005-04-21 AU AU2005236125A patent/AU2005236125C1/en not_active Ceased
- 2005-04-21 US US11/587,336 patent/US20090298053A1/en not_active Abandoned
- 2005-04-21 JP JP2007508731A patent/JP2007533311A/ja active Pending
- 2005-04-21 DE DE602005027065T patent/DE602005027065D1/de active Active
-
2011
- 2011-04-21 JP JP2011095389A patent/JP2011147456A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2005103703A3 (en) | 2006-07-13 |
EP2083273A1 (de) | 2009-07-29 |
EP1747465B1 (de) | 2011-03-23 |
DE602005027065D1 (de) | 2011-05-05 |
AU2005236125A1 (en) | 2005-11-03 |
EP2273271A3 (de) | 2011-04-13 |
AU2005236125B2 (en) | 2011-06-02 |
US20090298053A1 (en) | 2009-12-03 |
DK1747465T3 (da) | 2011-07-11 |
JP2011147456A (ja) | 2011-08-04 |
JP2007533311A (ja) | 2007-11-22 |
WO2005103703A2 (en) | 2005-11-03 |
EP1747465A2 (de) | 2007-01-31 |
AU2005236125C1 (en) | 2011-09-22 |
CA2563917A1 (en) | 2005-11-03 |
EP2273271A2 (de) | 2011-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1159249A1 (en) | Kit for the identification of ovarian cancer protein biomarkers using proteomic techniques | |
GB0612649D0 (en) | No title | |
WO2006081473A8 (en) | Methods for diagnosis and prognosis of epithelial cancers | |
DE60335022D1 (de) | Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel | |
WO2006012646A3 (en) | Amacr cancer markers | |
IL211255A0 (en) | Cop1 molecules and uses thereof | |
DE602007009645D1 (de) | Reagenzien und verfahren für krebsprognose und pathologische einstufung | |
MXPA06012232A (es) | Uso del patron proteogenomico del plasma para diagnostico, clasificacion, prediccion de respuesta a la terapia y comportamiento clinico, estratificacion de la terapia y monitoreo de enfermedad, en malignidades hematologicas. | |
EP2177614A3 (de) | Zusammensetzung und Verfahren zur Diagnose von Speiseröhrenkrebs sowie der Metastasierung von Speiseröhrenkrebs | |
ATE553382T1 (de) | Verwendungen von krebsspezifischen glykanen | |
SG141418A1 (en) | Method for the detection of gene transcripts in blood and uses thereof | |
WO2005042761A3 (en) | Biomarkers for amyotrophic lateral sclerosis | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
PL2211180T3 (pl) | Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworów | |
WO2004060302A3 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
EP2261672A3 (de) | Biomarker für den frühzeitigen Nachweis von Ovarialkarzinom | |
ATE503186T1 (de) | Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen proben | |
CA2701341A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
ATE454468T1 (de) | Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose | |
WO2006125021A3 (en) | Fibrinogen alpha and hemoglobin polypeptides as cancer markers | |
MXPA05004971A (es) | Pronostico para malignidad hematologica. | |
WO2007075672A3 (en) | Prognostic cancer markers | |
DE602005023329D1 (de) | VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8 | |
WO2008104985A3 (en) | Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1747465 Country of ref document: EP |